Rational Development of a Potent 15-Lipoxygenase-1 Inhibitor with in Vitro and ex Vivo Anti-inflammatory Properties-Reference-Cited by-同舟云学术

Rational Development of a Potent 15-Lipoxygenase-1 Inhibitor with in Vitro and ex Vivo Anti-inflammatory Properties

Published:2015-09-16 Issue:19 Volume:58 Page:7850-7862
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Eleftheriadis Nikolaos¹,Neochoritis Constantinos G.¹,Leus Niek G. J.¹,van der Wouden Petra E.¹,Dömling Alexander¹,Dekker Frank J.¹

Affiliation:

1. Department of Pharmaceutical Gene Modulation, ‡Department of Drug Design, Groningen Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands

Funder

European Research Council

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Innovative Medicine Initiative

National Institutes of Health

European Cooperation in Science and Technology

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5b01121

Reference51 articles.

1. Immunology of asthma and chronic obstructive pulmonary disease

2. Macrophage Heterogeneity in Respiratory Diseases

3. Monocyte and macrophage heterogeneity

4. Macrophage heterogeneity in tissues: phenotypic diversity and functions

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the Catalytic Site of Human 15‐Lipoxygenase‐1 via Marine Natural Products;Chemistry – A European Journal;2024-09-09

2. The hepatoprotective potential of tannic acid against doxorubicin‐induced hepatotoxicity: Insights into its antioxidative, anti‐inflammatory, and antiapoptotic mechanisms;Journal of Biochemical and Molecular Toxicology;2024-08

3. Pharmacological potential of Jussiaea repens L. against CuSO4 and bacterial lipopolysaccharide O55:B5 induced inflammation using in-vivo zebrafish models;Journal of Ethnopharmacology;2024-01

4. Dual COX-2/15-LOX inhibitors: A new avenue in the prevention of cancer;European Journal of Medicinal Chemistry;2023-12

5. Synthesis of new multitarget-directed ligands containing thienopyrimidine nucleus for inhibition of 15-lipoxygenase, cyclooxygenases, and pro-inflammatory cytokines;European Journal of Medicinal Chemistry;2023-08